Patent details

LUC00150 Product Name: Larotrectinib et/ou ses sels pharmaceutiquement acceptables, en particulier le sulfate de larotrectinib, y compris l'hydrogénosulfate de larotrectinib

Basic Information

Publication number:
LUC00150
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP161664610
Legal Status:
Inactive
Application number:
LUC00150
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/19/1385
Marketing Authorization Type:
Marketing Authorization Date:
23/09/2019
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
11/03/2020
First Marketing Authorization date:
23/09/2019
Grant date:
15/02/2021
Activation date:
Publication date:
13/03/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
23/09/2034
SPC Extension Expiration:
23/09/2034
Rejection date:
Withdrawal date:

Owner

From:
11/03/2020
 
 

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

Agent

Name:
ARONOVA S.A.
From:
11/03/2020
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/05
Publication date:
09/04/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/10/2029
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
11/03/2020 General Document 2
13/03/2020 Outgoing Correspondence 1
11/03/2020 Summary of the product caracteristics 78
15/02/2021 Certificate 1
11/03/2020 General Document 4
11/03/2020 Application Form 4
13/03/2020 Publication 1
15/02/2021 Publication 1
11/03/2020 Incoming Correspondence (Post) 1
11/03/2020 Incoming Correspondence (Post) 1
11/03/2020 General Document 4
12/02/2021 Incoming Correspondence (Post) 1
15/02/2021 Outgoing Correspondence 1